Lepu Biopharma Co., Ltd. (LEPU BIO) filed its Monthly Return to Hong Kong Exchanges for the period ended 30 June 2026, showing no movement in either authorised or issued share capital.

The authorised and registered capital closed the month unchanged at 1.80 billion ordinary H shares with a par value of RMB 1 each, amounting to RMB 1.80 billion in total.

Issued share capital also remained steady at 1.80 billion shares. The company held no treasury shares during the month, leaving total issued shares identical to the prior month.

LEPU BIO confirmed that its public float exceeded the Main Board’s minimum 25 % threshold, thereby remaining in full compliance with Hong Kong Listing Rule 13.32D.

The filing recorded no activity in share options, warrants, convertible securities, other share-issuance agreements, or Hong Kong Depositary Receipts.

The return was submitted on 6 July 2026 and signed by Joint Company Secretary Ms. Li Yunyi, affirming compliance with all applicable listing and regulatory requirements.